• Firdapse and Ruzurgi (Amifampridine)

  Ruzurgi Reimbursement Conditional in Canada – Flash Briefing

  Posted by Price Wooldridge on May 27, 2021 at 7:00 am

  An agency in Canada is recommending reimbursement for the cost of Ruzurgi for LEMS patients, with conditions. You’ll notice I said, “with conditions”.
  When reading this flash briefing, I got angry. I won’t editorialize here, and anything I say here is mine alone, not the position of BioNews Services, LLC.
  I’ll just say, I have some moral difficulties with this type of analyses being done on orphan drug status medications for rare diseases like LEMS. You can form your own opinion.

  Here is the Flash Briefing on the subject.

  https://soundcloud.app.goo.gl/kEpRvnZrBG63ubit9

  Price Wooldridge replied 2 years, 11 months ago 0 Member · 0 Replies

  • Amifampridine
  • Lambert- Eaton Myasthenic Syndrome
  • LEMS
  • rare disease
  • Ruzurgi
  • treatment
• 0 Replies

Log In to Reply